Indian Market for Clinical Trials Has Great Potential, According to Netscribes

23 Apr 2012 • by Natalie Aster

The Indian market for clinical trials has great potential. Due to the rapidly growing need for developing newer drugs, and the increasing spend on R&D by pharmaceutical companies; the market is exhibiting significant growth. This is providing contract research organizations the opportunity to expand their operations and earn higher incomes.

The new report “Clinical Trials Market in India 2012” by Netscribes (India) provides a snapshot of the clinical trials market. It begins with an introduction section which briefly discusses the various stages in clinical trials. This is followed by the market overview section which provides an insight into the market and highlights the market size and growth of clinical trials in the country. India’s current and projected share in the global clinical trials market has also been provided. The section also analyses the number of new trials registered in the country each year and segmentation of trials on the basis of the therapeutic area. The distribution of trials currently under progress, on the basis of the phase in which they are in, is also provided. Moreover the segmentation of trials on the basis of the sponsors has also been included in this section. The major pharmaceutical companies that are sponsoring trials in India have also been mentioned.

Report Details:

Clinical Trials Market in India 2012
Published: April, 2012
Pages: 58
Price: US$ 795,00

This is followed by an analysis of the drivers leading to growth in the market. This includes cost competitiveness, vast patient population with diverse number of diseases, increasing R&D expenditure by pharmaceutical companies, friendly regulatory environment, sound medical infrastructure and international quality standards. The main challenges to the market include shortage of research professionals, delays in trial approval, lack of data exclusivity and challenges of unethical trials. A section on government regulations in the industry has also been included. It covers the various government regulations outlining the legal and regulatory framework for conducting clinical trials in India.

The competition section provides an overview of the competitive landscape in the industry and includes a detailed profile of the major players in the market. The Porter’s Five Forces analysis for the clinical trials market is provided in this section. A summary of the major players operating in the market has also been provided in the form of a bubble chart. It also includes the list of products and services, key people, financial snapshot, key ratios and key recent developments for the major players.

A brief profile of the major clinical research institutes in the country and the key recent developments that have taken place in the market have been provided in the subsequent sections. A section providing strategic recommendations has been added at the end of the report which gives effective solutions to existing and potential players for improving market share and increasing their profitability.

More information can be found in the report “Clinical Trials Market in India 2012” by Netscribes (India).

To order the report or ask for sample pages contact ps@marketpublishers.com

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com